Home > News > Starpharma: Human Trials of Anti-HIV Product
July 31st, 2003
Starpharma: Human Trials of Anti-HIV Product
Abstract:
Melbourne biotech company Starpharma Pooled Development Ltd has received FDA clearance to proceed with human clinical trials of its new dendrimer nano-drug VivaGel. The gel will be used as a preventative against the transmission of HIV during sexual intercourse. It has been highly successful in preventing infection in monkey trials using a humanised strain of simian immunodeficiency virus.
Source:
Starpharma
Bookmark:
| Related News Press |
Nanomedicine
Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Self-propelled protein-based nanomotors for enhanced cancer therapy by inducing ferroptosis June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||